共 24 条
[1]
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ?3<ce:hsp sp="0.25"/>cm. Results of a multicenter Italian survey<!-- Doctopic: CAN -->[J] Maurizio Pompili;Antonio Saviano;Nicoletta de Matthaeis;Alessandro Cucchetti;Francesco Ardito;Bruno Federico;Franco Brunello;Antonio D. Pinna;Antonio Giorgio;Stefano M. Giulini;Ilario De Sio;Guido Torzilli;Fabio Fornari;Lorenzo Capussotti;Alfredo Guglielmi;Fabio Piscaglia;Luca Aldrighetti;Eugenio Caturelli;F
[2]
Facing the dawn of immunotherapy for hepatocellular carcinoma<!-- Doctopic: Editorial -->[J] Martin F. Sprinzl;Peter R. Galle Journal of Hepatology 2013,
[3]
Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection[J] Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko;Yusuke Kawamura;Hitomi Sezaki;Norio Akuta;Yoshiyuki Suzuki;Satoshi Saitoh;Yasuji Arase;Kenji Ikeda;Mariko Kobayashi;Hiromitsu Kumada Hepatology 2013,
[4]
Postoperative peg‐interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus‐related hepatocellular carcinoma[J] Yao‐Chun Hsu;Hsiu J. Ho;Ming‐Shiang Wu;Jaw‐Town Lin;Chun‐Ying Wu Hepatology 2013,
[5]
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors[J] Young-sun Kim;Hyo Keun Lim;Hyunchul Rhim;Min Woo Lee;Dongil Choi;Won Jae Lee;Seung Woon Paik;Kwang Cheol Koh;Joon Hyeok Lee;Moon Seok Choi;Geum-Youn Gwak;Byung Chul Yoo Journal of Hepatology 2013,
[6]
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study[J] Aziz Zaanan;Nicolas Williet;Mohamed Hebbar;Tienhan Sandrine Dabakuyo;Laetitia Fartoux;Touraj Mansourbakht;Olivier Dubreuil;Olivier Rosmorduc;Stéphane Cattan;Franck Bonnetain;Valérie Boige;Julien Taïeb Journal of Hepatology 2013,
[7]
Herbal Compound “Songyou Yin” Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness[J] Qing-An Jia;Zheng-Gang Ren;Yang Bu;Zhi-Ming Wang;Qiang-Bo Zhang;Lei Liang;Xue-Mei Jiang;Quan-Bao Zhang;Zhao-You Tang;Hui-Fen Liao Evidence-Based Complementary and Alternative Medicine 2012,
[8]
Sorafenib Down-regulates Expression of HTATIP2 to Promote Invasiveness and Metastasis of Orthotopic Hepatocellular Carcinoma Tumors in Mice[J] Wei Zhang;Hui–Chuan Sun;Wen–Quan Wang;Qiang–Bo Zhang;Peng–Yuan Zhuang;Yu–Quan Xiong;Xiao–Dong Zhu;Hua–Xiang Xu;Ling–Qun Kong;Wei–Zhong Wu;Lu Wang;Tian–Qiang Song;Qiang Li;Zhao–You Tang Gastroenterology 2012,
[9]
Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State[J] Isabel Garcia-Cao;Min Sup Song;Robin M. Hobbs;Gaelle Laurent;Carlotta Giorgi;Vincent C.J. de Boer;Dimitrios Anastasiou;Keisuke Ito;Atsuo T. Sasaki;Lucia Rameh;Arkaitz Carracedo;Matthew G. Vander Heiden;Lewis C. Cantley;Paolo Pinton;Marcia C. Haigis;Pier Paolo Pandolfi Cell 2012,
[10]
Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib[J] Anja Lachenmayer;Sara Toffanin;Laia Cabellos;Clara Alsinet;Yujin Hoshida;Augusto Villanueva;Beatriz Minguez;Hung-Wen Tsai;Stephen C. Ward;Swan Thung;Scott L. Friedman;Josep M. Llovet Journal of Hepatology 2012,